Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 6Breast Neoplasms 6Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Hepatocellular 3Small Cell Lung Carcinoma 2Lung Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Trauma, Nervous System 1Thoracic Injuries 1Stomach Neoplasms 1Skin Neoplasms 1Rectal Neoplasms 1Radiculopathy 1Pneumonia 1Pathologic Complete Response 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lymphoma 1Lung Diseases, Interstitial 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, B-Cell 1Leukemia 1Laryngeal Neoplasms 1Klippel-Feil Syndrome 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 36Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 19Papillomavirus Vaccines 16Vaccines 10Data Collection 9Blood Specimen Collection 5Vaccines, Synthetic 4artesunic acid 3artemisinin 3Engerix-B 3halofantrine 2epigallocatechin gallate 2artenimol 2Hepatitis A Vaccines 2GX-188 vaccine 2Colposcopy 2ranpirnase 1fludarabine 1Viusid 1Vitamin B 12 1VP-102 1VGX-3100 1Therapies, Investigational 1Sodium Chloride 1Pentetic Acid 1Observation 1Methods 1Measles-Mumps-Rubella Vaccine 1Interleukin-2 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Papillomavirus Infections × Observation × Clear all
NCT04528407 2025-02-13

BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects

BlueSky Immunotherapies GmbH

Completed
25 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡